Complete atrioventricular block associated with dapsone therapy: a rare complication of dapsone-induced hypersensitivity syndrome
- 7 July 2009
- journal article
- case report
- Published by Hindawi Limited in Journal of Clinical Pharmacy & Therapeutics
- Vol. 34 (4), 489-492
- https://doi.org/10.1111/j.1365-2710.2008.00991.x
Abstract
Dapsone is still widely used for a range of infectious and inflammatory diseases. A potential severe side‐effect, known as dapsone‐induced hypersensitivity syndrome (DHS), may occur. DHS is characterized by fever, skin rashes, lymphadenopathy and multiorgan dysfunction manifesting as hepatitis, cholangitis, pneumonitis, colitis, thyroiditis and myocarditis. However, DHS‐associated complete atrioventricular block has not previously been reported. We describe here a 45‐year‐old Chinese woman who developed DHS after 5 weeks of dapsone therapy for pustular palmoplantar psoriasis. In addition to typical DHS symptoms, she experienced several episodes of syncope as a result of complete atrioventricular block which was successfully reversed with a permanent pacemaker implantation.Keywords
This publication has 9 references indexed in Scilit:
- The Dapsone Hypersensitivity Syndrome revisited: a potentially fatal multisystem disorder with prominent hepatopulmonary manifestationsJournal of Occupational Medicine and Toxicology, 2006
- Fulminant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpesvirus 6 infectionJournal of the American Academy of Dermatology, 2006
- Dapsone Hypersensitivity Syndrome: A Clinico-Epidemiological ReviewThe Journal of Dermatology, 2005
- First report of supraventricular tachycardia after intravenous pulse methylprednisolone therapy, with a brief review of the literatureRheumatology International, 2005
- Hypersensitivity syndrome associated with dapsone/pyrimethamine (Maloprim) antimalaria chemoprophylaxisAnnals of Allergy, Asthma & Immunology, 2002
- Dapsone and sulfones in dermatology: Overview and updateJournal of the American Academy of Dermatology, 2001
- Rapid loss of insulin secretion in a patient with fulminant type 1 diabetes mellitus and carbamazepine hypersensitivity syndrome.JAMA, 2001
- Drug-Induced Methaemoglobinaemia Treatment IssuesDrug Safety, 1996
- TOXIC EFFECTS OF DIAMINODIPHENYL-SULPHONE IN TREATMENT OF LEPROSYThe Lancet, 1951